Sadržaj· 3 poglavlja
Šta kažu studije
Uvećana prostata (smetnje pri mokrenju)
SpornoPregledi se ne slažu. Meta-analiza heksanskog ekstrakta (2018): manje noćnog mokrenja i bolji protok u odnosu na placebo, sličan efekat kao tamsulozin i kratkotrajni 5-ARI. Mrežna meta-analiza (2021): nema klinički značajnog poboljšanja. Meta-analiza (2021): sama S. repens možda ne daje kliničku korist.PMID 29694707 · PMID 31952967 · PMID 34488251
Kosa (opadanje)
SlaboSistematski pregled iz 2020 beleži poboljšanja kvaliteta kose u pojedinim studijama sa različitim preparatima; preparati su dobro podnošljivi.PMID 33313047
Ocena važi za tu namenu, ne za dodatak uopšte. Šta znači koja ocena: legenda u bazi.
Bezbednost i na šta paziti
Izvori
- Serenoa repens (saw palmetto): a systematic review of adverse events. Drug Saf, 2009. PMID 19591529
- Efficacy and safety of a hexanic extract of Serenoa repens (Permixon(®) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies. BJU Int, 2018. PMID 29694707
- Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus, 2021. PMID 31952967
- Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Am J Mens Health, 2020. PMID 32274957
- Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia. Skin Appendage Disord, 2020. PMID 33313047
- Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis. Investig Clin Urol, 2021. PMID 34488251
- Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials. Arch Ital Urol Androl, 2021. PMID 34933534
Literatura poslednji put proverena: 19. oktobar 2026.. Tekst je informativan i ne zamenjuje savet lekara. Ne tvrdimo da bilo koji dodatak leči bilo koje stanje.
